MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ahj.2026.107592

Медицинская библиотека · American heart journal · 2026

Clinical outcomes associated with recurrent compared to first-time myocardial infarction.

Christensen Daniel Mølager, Garred Caroline Hartwell, Malmborg Morten, Sindet-Pedersen Caroline, Zahir Deewa, Nouhravesh Nina, Fosbøl Emil, Docherty Kieran F, Butt Jawad H, McMurray John J V, Petrie Mark C, Pfeffer Marc A, Køber Lars, Schou Morten

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Patients with recurrent myocardial infarction (MI) are a heterogenous group with high comorbidity burden, risk of complex coronary disease, and at risk of poor outcomes. However, contemporary comparative data are lacking.

METHODS

Consecutive patients with recurrent MI (defined as a new hospital admission for MI > 28 days following a first-time MI) in Denmark between 2015 and 2022 were identified through the nationwide registries and matched 1:1 on age and sex to patients with first-time MI. The primary outcome was a composite of all-cause mortality, hospitalization for heart failure (HHF), and further recurrent MI. Standardized risks with 95% confidence intervals (CI) were estimated using cause-specific Cox regression models with first-time MI serving as the reference group.

RESULTS

A total of 8,397 patients with recurrent MI and 8,397 with first-time MI were included (median age 73, 70.7% male). Patients with recurrent MI had more comorbidities. For the primary composite outcome, patients with recurrent MI had a standardized 1-year risk of 24.0% vs 17.2% among those with first MI (standardized risk ratio [sRR] 1.39 [95% CI: 1.34-1.44]). They also had higher risks of: all-cause mortality, 14.6% vs 11.3% (sRR 1.29 [1.24-1.35]); HHF, 6.6% vs 6.0% (sRR 1.11 [1.00-1.21]), and recurrent MI 6.7% vs 2.2% (sRR 3.01 [2.71-3.45]). Use of guideline-recommended treatments postdicharge was high, albeit lower than for first-time MI: percutaneous coronary intervention (53.7% vs 64.3%, P < .001), lipid-lowering treatment (78.1% vs 83.2%, P < .001), and P2Y12 inhibitor (77.3% vs 82.6%, P < .001).

CONCLUSION

Recurrent MI is associated with a higher risk of all-cause mortality, HHF, and further recurrent MI compared with first-time MI.

Для цитирования: Christensen Daniel Mølager, Garred Caroline Hartwell, Malmborg Morten, Sindet-Pedersen Caroline, Zahir Deewa, Nouhravesh Nina, Fosbøl Emil, Docherty Kieran F, Butt Jawad H, McMurray John J V, Petrie Mark C, Pfeffer Marc A, Køber Lars, Schou Morten. Clinical outcomes associated with recurrent compared to first-time myocardial infarction.. American heart journal. 2026. DOI: 10.1016/j.ahj.2026.107592.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.